Coherus BioSciences Inc (NAS:CHRS)
$ 1.76 0 (0%) Market Cap: 201.34 Mil Enterprise Value: 423.31 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 42/100

Coherus BioSciences, Inc., Surface Oncology, Inc. - M&A Call Transcript

Jun 16, 2023 / 12:30PM GMT
Release Date Price: $4.13 (-23.38%)
Operator

Good day, and thank you for standing by. Welcome to the Coherus and Surface Oncology Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your speaker today. Marek, please go ahead.

Marek Ciszewski
Coherus BioSciences, Inc. - SVP of IR

Thank you, Latanya, and good morning, everybody. Today's call includes forward-looking statements regarding the proposed transaction for the terms of the agreement and plan of merger among Coherus BioSciences and Surface Oncology and their affiliates. These forward-looking statements include, but are not limited to, statements regarding the business combination and related matters, including, but not limited to, satisfaction of closing conditions, prospective performance and opportunities with respect to Coherus or Surface, post-closing operations and the outlook for the company's businesses, Coherus', Surface's or the combined company's targets, plans and objectives or goals for future operations, including those related to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot